Back | Next |
home / stock / ardx / ardx message board
Subject | By | Source | When |
---|---|---|---|
Well they definitely want XPHOZAH approved in | Whalatane | investorshub | 04/05/2023 6:34:57 PM |
Thx for the detail . I think this | Whalatane | investorshub | 04/05/2023 3:57:34 AM |
$ARDX 4/5/23 Looking for some support??? | TripTrap | investorshub | 04/05/2023 2:30:12 AM |
They didn't see the benefit of using the | Cosa | investorshub | 04/05/2023 12:18:15 AM |
Not sure, not a doctor or scientist. | Cosa | investorshub | 04/05/2023 12:04:55 AM |
Cosa .Do U know how they plan to | Whalatane | investorshub | 04/04/2023 8:55:23 PM |
Benny Thx for making me look at $ARDX | Whalatane | investorshub | 04/04/2023 8:01:06 PM |
Well thanks, looking like market is still | Outcast27 | investorshub | 03/31/2023 3:04:23 PM |
Scripts for Ibsrela are steadily climbing and NDA | Cosa | investorshub | 03/29/2023 7:29:22 PM |
Well let's hope it holds itself up. | Outcast27 | investorshub | 03/29/2023 6:29:07 PM |
Yup. Accumulation by retail and institution. | Cosa | investorshub | 03/21/2023 11:20:23 PM |
Well once again MM playing with this. Same | Outcast27 | investorshub | 03/20/2023 2:49:06 PM |
Looks like you were wrong. In a | Cosa | investorshub | 03/17/2023 8:40:10 PM |
You will see. No company has anything close | Outcast27 | investorshub | 03/17/2023 2:33:01 AM |
God bless your wife. But why is this | Alan Brown | investorshub | 03/17/2023 2:14:23 AM |
I say yes. People need this drug. | Outcast27 | investorshub | 03/16/2023 7:36:47 PM |
Unfortunately the market has becoming more rational these | Alan Brown | investorshub | 03/16/2023 1:24:29 PM |
Its all up to the FDA. The | Cosa | investorshub | 03/10/2023 10:13:26 PM |
New Standard of Care potential. | Cosa | investorshub | 03/10/2023 9:56:38 PM |
Let them drop the price, opportunity for others | Cosa | investorshub | 03/10/2023 9:53:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...